Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSEnavogliflozin is an inhibitor of sodium-glucose cotransporter 2 (SGLT2; IC50 = 0.46 nM).1 It is selective for SGLT2 over SGLT1 (IC50 = 359 nM). Enavogliflozin increases urinary glucose excretion in rats. It also decreases blood glucose and hemoglobin A1c (HbA1c) levels in rodent models of type 1 and type 2 diabetes at 0.5 mg/kg.
WARNING This product is not for human or veterinary use.
1. Discovery of GCC5694A: A potent and selective sodium glucose co-